EligibleTrials
Drugs & treatments › Glutaminase-1 Inhibitor IACS-6274

Glutaminase-1 Inhibitor IACS-6274: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
15
Conditions studied
1
US states with sites
1
Countries

Phase breakdown

Phase 1 1

Conditions being studied

ConditionTrials
Advanced Endometrial Carcinoma1
Advanced Head and Neck Squamous Cell Carcinoma1
Advanced Malignant Solid Neoplasm1
Advanced Melanoma1
Advanced Ovarian Clear Cell Adenocarcinoma1
Chondrosarcoma1
Clinical Stage III Cutaneous Melanoma AJCC v81
Clinical Stage IV Cutaneous Melanoma AJCC v81
Melanoma1
Pathologic Stage III Cutaneous Melanoma AJCC v81
Pathologic Stage IIIA Cutaneous Melanoma AJCC v81
Pathologic Stage IIIB Cutaneous Melanoma AJCC v81
Pathologic Stage IIIC Cutaneous Melanoma AJCC v81
Pathologic Stage IIID Cutaneous Melanoma AJCC v81
Pathologic Stage IV Cutaneous Melanoma AJCC v81

Recruiting trials involving Glutaminase-1 Inhibitor IACS-6274

Common questions

How many recruiting trials involve Glutaminase-1 Inhibitor IACS-6274?

1 recruiting trial across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.